Abiopharma

Financial Statements and Related Announcement: Discrepancies between unaudited and audited accounts

New Form DEFA14A - SIERRA BANCORP <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001104659-26-040185 <b>Size:</b> 424 KB

ASCENDIS PHARMA A/S (ASND) Files Form 6-K

(50% Neutral) ARLO TECHNOLOGIES, INC. (ARLO) Announces Regulatory Update

New Form DEF 14A - SIERRA BANCORP <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001104659-26-040182 <b>Size:</b> 3 MB

CALEDONIA MINING CORP PLC (CMCL) Files Form 6-K

Natera - 20 Abstracts at AACR Highlight Scale, Innovation and Clinical Impact of Natera’s Oncology Platform

New Form 4/A - GREENLIGHT CAPITAL RE, LTD. <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001385613-26-000052 <b>Size:</b> 5 KB

CHUNGHWA TELECOM CO LTD (CHT) Files Form 6-K

New Form PRE 14A - OFS Capital Corp <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001487918-26-000028 <b>Size:</b> 1 MB

Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential

JELL-O Introduces the JELL-OMETER: the Worlds First-Ever Device to Quantifiably Measure Fan Intensity

Serina Therapeutics to Present at the 5th LNP Formulation & Process Development Summit

Lifezone Produces First-Ever Platinum, Palladium and Rhodium from its U.S. PGM Recycling Project

Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential